T2 Biosystems Inc expected to post a loss of $1.20 a share - Earnings Preview

T2 Biosystems

19/05/2023 14:00

* T2 Biosystems Inc  TTOO.OQ   TTOO.O  is expected to show a
fall
in quarterly revenue when it reports  results on May 22. 
    * The Lexington Massachusetts-based  company is expected to
report
 a 67.7% decrease in revenue to $2.333 million from $7.23
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for T2 Biosystems Inc
is for
a loss of $1.20 per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for T2
Biosystems Inc
is $0.58​, above​ its last closing price of $0.27. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -1.67       -1.70      -1.41     Beat    17.3
 Sep. 30 2022  -2.05       -2.04      -2.95     Missed  -44.4
 Jun. 30 2022  -4.50       -4.50      -5.00     Missed  -11.1​
 Mar. 31 2022  -3.72       -3.75      -5.00     Missed  -33.3
 ​​Dec.        -4.50       -4.50      -3.50     Beat    22.2
 31 2021                                                
 Sep. 30 2021  -4.23       -4.25      -4.00     Beat    5.9​
 Jun. 30 2021  -4.00       -4.00      -4.00     Met     0
 Mar. 31 2021  -3.83       -3.70      -3.50     Beat    5.4
 This summary was machine generated May 19 at 13:00 GMT.  All
figures in US dollars  unless otherwise stated